Stryker (NYSE:SYK) yesterday filed to extend the anti-trust deadline on its $1.4 billion acquisition of K2M (NSDQ:KTWO) to give the U.S. Federal Trade Commission more time to examine the deal, as shareholders filed suit to block the merger, K2M said today. The new FTC filing pushes the anti-monopoly waiting period out to Nov. 16, the Leesburg, Va.-based spinal […]
“Snake oil” BP app got high user marks despite inaccurate results
People may like mobile blood pressure apps better when the apps reveal positive results, even if those results are inaccurate 80% of the time, according to a recent study. A team of researchers who previously revealed the inaccuracy of the Instant Blood Pressure (IBP) app returned to the topic to study 81 adults who compared the app’s readings […]
FTC files complaint against Schein, Benco, Patterson over alleged denial of biz to buying groups
The U.S. Federal Trade Commission this week filed a complaint against Henry Schein (NSDQ:HSIC), Patterson (NSDQ:PDCO) and Benco alleging violations of US antitrust law by conspiring to refuse to provide discounts to or to serve buying groups representing dental practitioners, according to a new FTC posting. The three companies, which the FTC claims control more than 85% of […]
FDA, FTC warn companies over deceptive opioid cessation products
The FDA and the Federal Trade Commission have posted joint warning letters to companies that make and distribute opioid cessation products. The two watchdogs warned that the companies are illegally marketing their unapproved products as treatments or even cures for people with opioid addiction and withdrawal. Selling unapproved products as therapies for opioid addiction is […]
Anti-trust regulators want more from BD, Bard on $24B merger
Becton Dickinson & Co. (NYSE:BDX) and C.R. Bard (NYSE:BCR) said last week that the U.S. Federal Trade Commission wants more information on their pending $24 billion merger. The move adds 30 days to the timeline for closing the $317-per-share deal, the companies said, but the acquisition is still slated to close in the fall. “BD and Bard […]
Senate panel adds to call for hearings over Mylan’s EpiPen pricing
The U.S. Senate Judiciary Committee yesterday called on the Federal Trade Commission to investigate whether Mylan (NSDQ:MYL) broke the law after reports claimed the EpiPen maker prevented schools from buying competing allergy treatments. In a letter penned to the FTC, committee chairman Sen. Charles Grassley (R-Iowa) and ranking member Sen. Patrick Leahy (D-Vt.) wrote, “increasing patient access […]
US Senators urge FTC to probe Baxter, Braun & Hospira saline prices
Four U.S. Senators yesterday wrote the FTC urging a probe into possible illegal saline price inflation of 200-300% since a shortage of the fluid began in late 2013. The letter, sent to FTC chairwoman Edith Ramirez, was signed by Conn. dem senator Richard Blumenthal, Minn. dem Amy Klobuchar and Utah reps. Mike Lee and Orrin […]
Justice Dept., FTC probe Valeant’s Bausch & Lomb, Paragon lens operations
The U.S. Justice Dept. and the Federal Trade Commission are investigating Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) subsidiaries Bausch & Lomb and Paragon Vision Sciences, the Canadian drug maker said yesterday. The Justice Dept. is looking into payments Bausch & Lomb made to doctors using its Crystalens intra-ocular lens and Victus eye laser, Valeant said yesterday in a regulatory […]
Steris, Synergy delay shareholder votes ahead of anti-trust ruling on $2B merger
Steris (NYSE:STE) and Synergy Health postponed their shareholders meetings to give a U.S. court time to rule on the Federal Trade Commission’s bid to halt their $1.9 billion merger. Mentor, Ohio-based Steris said it moved its meeting from Sept. 24 to Oct. 2; Synergy plans to hold its vote the same day, according to a regulatory filing. Earlier […]
FDA approves STJ’s MRI-safe SCS device | Regulatory news for the week of May 4, 2015
FTC: We might force M&A divestitures in outside markets
The U.S. Federal Trade Commission last week said it may force companies to divest assets outside of the market the anti-monopoly bureau its trying to regulate.
MassDevice Network
@MassDevice
LinkedIn